Sep 07, 2023 / 05:30PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to host this session with Stryker. From the company, we have Glenn Boehnlein, the CFO; and Jason Beach, the Vice President of Investor Relations.
In terms of format, it's going to be a fireside chat. If anybody has a question, just raise your hand. We'll come around with a mic. Glenn and Jason, thanks so much for being here. Thank you.
Glenn S. Boehnlein - Stryker Corporation - VP & CFO
Thank you. Thanks for having us.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research AnalystSo someone -- Louis, can you close the door, please? Can someone just close the door? Thanks. So let's start, Glenn, at a high level here. Stryker had a really impressive first half, I think 12% organic growth. Could you talk about the momentum